sp. bacterium and use thereof
Number of patents in Portfolio can not be more than 2000
United States of America
Stats
-
Mar 25, 2025
Grant Date -
Mar 10, 2022
app pub date -
Dec 24, 2019
filing date -
Dec 24, 2019
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention relates to the strain of Holdemanella biformis CECT 9752, its cellular components, metabolites, and secreted molecules, and to compositions comprising the aforementioned products, in addition to the use of said strain, but also to the genus Holdemanella, and to the species H. biformis for preventing alterations in energy homeostasis and glucose metabolism, including, glucose intolerance, insulin resistance, metabolic syndrome and diabetes.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully